MSKCC: Probability of lymph node involvement in prostate cancer patients Ap - Evidencio
MSKCC: Probability of lymph node involvement in prostate cancer patients April 2018 Update
Calculates the probability that prostate cancer has spread to the pelvic lymph nodes (c-index: 0.85). This model does not require information regarding the number of biopsy cores. 

Disqualifying treatments: This model does not apply to patients who underwent preoperative hormone- or radiation therapy for prostate cancer. 
Autores de la investigación: Source: Memorial Sloan Kettering Cancer Center (US)
Versión: 1.1
  • Público
  • Oncología
  • {{ modelType }}
  • Detalles
  • Validar algoritme
  • Guardar entrada
  • Entrada de carga
Mostrar
Unidades

{{ section.title }}

{{ section.description }}

Calcular el resultado

Establezca más parámetros para realizar el cálculo

Probability of lymph node involvement:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Intervalo de resultados {{ additionalResult.min }} a {{ additionalResult.max }}

Información condicional


How this model should be used:
This model calculates the probability that prostate cancer has spread to the pelvic lymph nodes. The model does not apply to patients who underwent preoperative hormone- or radiation therapy for prostate cancer. 

Model performance: 
A validation was performed to assess the discriminative power of the model. On the website of the MSKCC, a c-index of 0.85 is reported. No specific details regarding the validation process are disclosed.

Alternative models: 
For cases in which the number of cores taken at biopsy is known, an alternative prediction model including this information is available, although addition of biopsy core information did not improve the discriminative power of the model (c-index 0.86 in both models).


Source: Memorial Sloan Kettering Cancer Center.

{{ file.classification }}
PRO
Nota
Las notas sólo son visibles en la descarga de resultados y no serán guardadas por Evidencio

Este algoritme se proporciona con fines educativos, formativos e informativos. No debe utilizarse para apoyar la toma de decisiones médicas ni para prestar servicios médicos o de diagnóstico. Lea nuestro disclaimer.

Algoritmer subyacentes Parte de
Comentarios
Comentario
Escriba un comentario
Los comentarios son visibles para cualquiera

Comentarios sobre el algoritme

Aún no hay comentarios 1 comentario {{ model.comments.length }} Comentarios
En {{ comment.created_at }} {{ comment.user.username }} un autor ya no registrado escribió:
{{ comment.content }}
logo

Inicia sesión para activar las funciones de impresión de Evidencio

Para poder utilizar las funciones de impresión de Evidencio, debe estar conectado.
Si no tiene una cuenta de la Comunidad Evidencio puede crear su cuenta personal gratuita en:

https://www.evidencio.com/registration

Resultados impresos - Ejemplos {{ new Date().toLocaleString() }}


Beneficios de la Cuenta Comunitaria Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Descargo de responsabilidad: Los cálculos por sí solos nunca deben dictar la atención al paciente, y no sustituyen al juicio profesional.
Evidencio v3.38 © 2015 - 2025 Evidencio. Todos los derechos reservados